InvestorsHub Logo
Followers 116
Posts 13861
Boards Moderated 0
Alias Born 03/16/2014

Re: None

Wednesday, 04/10/2024 10:29:17 AM

Wednesday, April 10, 2024 10:29:17 AM

Post# of 211
Nice !
We ended 2023 with more than $100 million in cash, restricted cash, cash equivalents and investments. Based on our current cash position and operational plans, we believe our financial resources are sufficient to fund the Company’s operations through the filing of a Biologics License Application (BLA) for efzofitimod in pulmonary sarcoidosis."

$LIFE
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LIFE News